SNPS AI Stock Analysis – Buy, Hold, or Avoid?
Synopsys, Inc. (SNPS)
Fundamentals
Synopsys, Inc. demonstrates steady revenue growth and strong earnings quality despite margin pressures in recent quarters. The company maintains solid profitability with robust gross margins and ongoing investments in R&D underpinning its technology leadership. However, recent sequential margin compression and net income volatility signal challenges in cost management and macro uncertainties.
Financial Highlights
- Revenue
- Net Income
- Net Margin (%)
Revenue
41.87% YoY
Q1 2026
Net Income
-95.05% YoY
Q1 2026
Net Margin
Q1 2026
Growth Metrics
Revenue Growth YoY
Latest Quarter: Q1 2026
Net Income Growth YoY
Latest Quarter: Q1 2026
Revenue Per Share Growth YoY
Latest Quarter: Q1 2026
EPS Growth YoY
Latest Quarter: Q1 2026
Book Value Per Share Growth YoY
Latest Quarter: Q1 2026
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.3B | 2.4B | 2.3B | 1.7B | 1.6B | 1.5B | 1.6B | 1.5B |
| Revenue Growth YoY | +41.87% | +65.52% | +37.83% | +14.03% | +10.28% | -3.68% | +2.30% | +12.65% |
| Net Income | 17.1M | 64.7M | 448.7M | 242.5M | 345.3M | 295.7M | 1.1B | 408.1M |
| Net Income Growth YoY | -95.05% | -78.11% | -59.73% | -40.57% | +18.22% | -34.16% | +219.05% | +21.35% |
| EPS | $0.09 | $0.40 | $2.42 | $1.51 | $2.25 | $1.91 | $7.24 | $2.66 |
| EPS Growth YoY | -96.00% | -79.06% | -66.57% | -43.23% | +17.80% | -35.25% | +214.78% | +20.36% |
Profitability Metrics
Technical Analysis
SNPS is currently in a strong downtrend, trading below all major moving averages with a confirmed death cross, indicating bearish price momentum. Key support near $366-$368 is crucial, while resistance is observed around $385-$390, with recent price action rejecting higher levels. Mixed MACD signals and a neutral RSI suggest momentum is uncertain, but overall technical evidence supports a bearish outlook in the near term.
No extreme reading
Price in downtrend
Range-bound market
50 below 200 - bearish
Key Technical Values
Price with Moving Averages
50-day, 150-day and 200-day simple moving averages
Relative Strength Index
Momentum oscillator measuring speed and magnitude of price changes
RSI (14)
Earnings
Synopsys, Inc. demonstrates steady revenue growth and strong earnings quality despite margin pressures in recent quarters. The company maintains solid profitability with robust gross margins and ongoing investments in R&D underpinning its technology leadership. However, recent sequential margin compression and net income volatility signal challenges in cost management and macro uncertainties.
Latest Earnings
Q1 2026 Earnings (Apr 30, 2026)
Earnings Per Share (EPS)
Actual
$3.35
Estimated
$3.15
Surprise
+$0.20
Surprise %
+6.35%
Revenue
Actual
$2.28B
Estimated
$2.25B
Surprise
+$25.1M
Surprise %
+1.12%
Historical Earnings
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share | ||||||||
| EPS (Actual) | $3.35 | $3.77 | $2.90 | $3.39 | $3.67 | $3.03 | $3.40 | $3.43 |
| EPS (Estimated) | $3.15 | $3.56 | $2.78 | $3.80 | $3.39 | $2.79 | $3.30 | $3.28 |
| EPS Surprise | +$0.20 | +$0.21 | +$0.12 | -$0.41 | +$0.28 | +$0.24 | +$0.10 | +$0.15 |
| % Diff | +6.3% | +5.9% | +4.3% | -10.8% | +8.3% | +8.6% | +3.0% | +4.6% |
| Revenue | ||||||||
| Revenue (Actual) | $2.28B | $2.41B | $2.25B | $1.74B | $1.6B | $1.46B | $1.64B | $1.53B |
| Revenue (Estimated) | $2.25B | $2.39B | $2.25B | $1.77B | $1.6B | $1.45B | $1.63B | $1.52B |
| Revenue Surprise | +$25.1M | +$18.95M | +$7.51M | -$28.69M | +$2.86M | +$3.65M | +$5.11M | +$5.67M |
| % Diff | +1.1% | +0.8% | +0.3% | -1.6% | +0.2% | +0.3% | +0.3% | +0.4% |
Valuation
Synopsys (SNPS) currently trades at a premium valuation with notably high multiples relative to its sector peers, reflecting strong expectations around its AI-driven growth initiatives and market positioning. Despite earnings growth challenges in recent quarters, solid revenue growth and strategic collaborations provide a rationale for the current valuation, supported by a bullish analyst consensus and significant upside potential based on price targets.
Valuation Metrics
Price to Earnings
TTM
Price to Sales
TTM
Price to Book
TTM
Enterprise Value to EBITDA
TTM
Enterprise Value to Revenue
TTM
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Price to Earnings | 1340.56 | 290.70 | 46.88 | 104.88 | 51.00 | 68.78 | 17.74 | 52.47 |
| Price to Sales | 40.40 | 30.93 | 32.24 | 58.32 | 44.33 | 55.75 | 48.32 | 56.14 |
| Price to Book | 3.02 | 2.44 | 2.57 | 3.67 | 7.17 | 8.72 | 8.79 | 11.11 |
| Enterprise Value to EBITDA | 164.78 | 169.87 | 72.47 | 253.35 | 125.57 | 223.45 | 167.22 | 183.67 |
| Enterprise Value to Revenue | 44.10 | 34.56 | 37.30 | 65.57 | 42.22 | 53.70 | 46.36 | 55.38 |
Sentiment & Analyst Ratings
Synopsys (SNPS) currently exhibits a mixed to moderately positive market sentiment anchored by strong analyst buy ratings and solid recent earnings growth, despite a notable price decline over the last year. News coverage is active and generally positive regarding company performance and outlook, but cautious investor sentiment is evident from rising short interest and insider selling. Social media and retail mood are divided, reflecting uncertainties around valuation and broader market headwinds impacting the semiconductor sector.
Analyst Recommendations
Risk Assessment
Synopsys exhibits a moderate financial risk profile with solid liquidity and manageable leverage despite significant debt from recent acquisitions. The company operates in a competitive and geopolitically sensitive industry with notable risks related to global trade restrictions, integration of acquisitions, and customer concentration. While growth prospects remain strong, ongoing macroeconomic and regulatory challenges temper the near-term risk outlook from an investor perspective.
Liquidity & Solvency
Current Ratio
Latest Quarter: Q1 2026
Quick Ratio
Latest Quarter: Q1 2026
Debt-to-Equity
Latest Quarter: Q1 2026
Debt-to-Assets
Latest Quarter: Q1 2026
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Liquidity Metrics | ||||||||
| Current Ratio | 1.43 | 1.36 | 1.62 | 1.62 | 7.02 | 2.68 | 2.44 | 2.02 |
| Quick Ratio | 1.32 | 1.26 | 1.52 | 1.51 | 6.85 | 2.51 | 2.30 | 1.87 |
| Solvency Metrics | ||||||||
| Debt-to-Equity | 0.36 | 0.36 | 0.50 | 0.55 | 1.08 | 0.07 | 0.08 | 0.09 |
| Debt-to-Assets | 0.23 | 0.23 | 0.30 | 0.31 | 0.45 | 0.05 | 0.05 | 0.06 |
Liquidity Assessment
Current Ratio: 1.43(Adequate)
Quick Ratio: 1.32(Strong)
The company has adequate liquidity but may face challenges in a downturn.
Solvency Assessment
Debt-to-Equity: 0.36(Low)
Debt-to-Assets: 0.23(Low)
The company maintains a balanced capital structure with manageable debt levels.
Frequently Asked Questions about SNPS
AI Answers: Common Questions About SNPS
Get AI-powered answers to the questions investors ask most about Synopsys, Inc.
Synopsys is a good long-term buy given its 20%+ revenue growth, strong market position, and AI innovation. However, short-term technical weakness suggests caution before entering.
Selling is advisable in the short term due to bearish technical signals and resistance near $385-$390. Hold or accumulate on pullbacks for medium to long-term investors.
Key risks include semiconductor cyclicality, margin pressure from rising expenses, geopolitical trade restrictions, and integration challenges from acquisitions.
Analyst median price targets are near $570, implying ~46% upside from current $388.76, supported by growth and earnings recovery expectations.
The stock trades at a high trailing P/E of ~29 and elevated price-to-sales multiples, justified by strong revenue growth and AI-driven innovation but sensitive to earnings volatility.
Fundamentals show steady revenue growth from $5.3B in 2023 to $7.1B in 2025, high gross margins (~73-80%), but recent operating margin decline to ~10% due to rising costs.
Technically bearish with a confirmed death cross, price below all major moving averages, and support near $366 critical. Momentum indicators are neutral to negative.
Upcoming earnings reports, AI product launches, and margin stabilization could catalyze positive price movement.
Want a Personalized Answer?
Get AI-powered insights tailored to your risk tolerance and investment goals.